{"count":1,"next":null,"previous":null,"results":[{"gene_data":{"alias":["4T2HC","4F2","NACAE","CD98","CD98HC","4F2HC"],"biotype":"protein_coding","hgnc_id":"HGNC:11026","gene_name":"solute carrier family 3 member 2","omim_gene":["158070"],"alias_name":["antigen identified by monoclonal antibodies 4F2, TRA1.10, TROP4, and T43","antigen defined by monoclonal antibody 4F2","heavy chain","4F2 heavy chain","CD98 heavy chain","monoclonal antibody 44D7","4F2 cell-surface antigen heavy chain","lymphocyte activation antigen 4F2 large subunit"],"gene_symbol":"SLC3A2","hgnc_symbol":"SLC3A2","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"11:62623518-62656352","ensembl_id":"ENSG00000168003"}},"GRch38":{"90":{"location":"11:62856102-62888875","ensembl_id":"ENSG00000168003"}}},"hgnc_date_symbol_changed":"1994-02-15"},"entity_type":"gene","entity_name":"SLC3A2","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["NHS GMS"],"phenotypes":["no disorder assigned on OMIM - possible role in immune function based on mouse studies."],"mode_of_inheritance":"","tags":[],"panel":{"id":168,"hash_id":"55b605f722c1fc05fd2345af","name":"Craniosynostosis","disease_group":"Skeletal disorders","disease_sub_group":"Craniosynostosis syndromes","status":"public","version":"2.0","version_created":"2019-09-17T13:00:09.542482Z","relevant_disorders":["Craniosynostosis syndromes","Craniosynostosis syndromes phenotypes","Rare syndromic craniosynostosis or isolated multisuture synostosis","R100"],"stats":{"number_of_genes":114,"number_of_strs":0,"number_of_regions":2},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"GMS signed-off","slug":"gms-signed-off","description":"This panel has undergone review by a NHSE GMS disease specialist group and processes to be signed-off for use within the GMS."}]}}]}